65,437 trials
Obesity · Overweight
Primary: Co-primary: Body Weight- Mean Percent Change — -5.00; -6.14; -1.33 percentage of body weight — p=<0.001
Anxiety Disorders · Somatoform Disorders
Primary: Phase II Relapse of Body Dysmorphic Disorder (BDD) Symptoms (as Measured by the BDD-YBOCS) — 18; 40 percentage of subjects who relapsed — p=0.048
Obesity · Overweight
Primary: Co-primary: Body Weight- Mean Percent Change From Baseline to Week 28 — -6.45; -1.89 percentage of body weight — p=<0.001
Rheumatoid Arthritis · Psoriatic Arthritis
Primary: Percentage of Successful Self-injections to Total Non-missed Injections — 97.8 percentage of successful injections
Healthy Volunteers
Primary: Tear Lipid Composition Profile — 39.34; 0.76; 6.58; 1.48 pmole
Obesity · Overweight · Diabetes Mellitus, Type 2
Primary: Co-primary: Body Weight- Mean Percent Change — -5.03; -1.75 percentage of body weight — p=<0.001
Anesthesia
Primary: Lymphocyte Count — 0.55; 0.73; 0.73 cells/nanoliter
Hyperglycemia · Acute Coronary Syndromes · Myocardial Infarction
Primary: Median Glucose Values From Steady State Through 48 Hours or Until Discharge. — 132; 127; 105 mg/dL — p=<0.001
Fracture of Ankle
Primary: Quality of Recovery — 181; 184; 181 units on a scale
Hearing Loss, Noise-Induced
Primary: Percentage of Time Spent at Sound Levels >80 Decibels — 4.4; 5.0; 6.3 percentage of time — p=0.289
Melanoma (Skin)
Primary: Safety: Grade 3 Adverse Events — 1; 0 participants
Carcinoma, Non-Small-Cell Lung
Primary: Progression Free Survival (PFS) as Assessed by Central Independent Review — 4.4; 3.6 months — p=0.0435
Multiple Myeloma
Primary: Percentage of Patients With an Objective Response — 31 percentage of patients
Sepsis · Renal Failure · Pulmonary Edema
Primary: Survival — 86; 92 percentage of participants
Stress Disorders, Posttraumatic · Tobacco Use Disorder
Primary: Smoking Abstinence, Self-reported — 5; 11 participants